Streetbeat News

Partnerships

VTAK

Catheter Precision has secured its first purchase order for its product, LockeT, in the Greater Chicago area, marking an expansion into a new U.S. territory with Endeavor Health System.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 12:34 pm

REBN

Reborn Coffee is expanding into China through a master license agreement, establishing premier locations in Chengdu, Sichuan Province. This strategic move aims to tap into the growing Chinese coffee market.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 12:33 pm

BNTX

TEM

Tempus AI, Inc. and BioNTech SE have announced a multi-year collaboration to enhance BioNTech's oncology pipeline using Tempus' multimodal datasets. This partnership aims to generate insights into biological mechanisms for developing new cancer therapies.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 12:33 pm

IVDA

Iveda has announced the application of its AI vision software, vumastAR, to recognize oil spills for safety applications with major oil companies in Australia and the U.S. This technology is part of proof-of-concept projects aimed at enhancing safety in the oil and gas industry.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 12:32 pm

SEAT

Vivid Seats Inc. (NASDAQ:SEAT) has announced a multiyear media partnership with I Am Athlete, founded by Brandon Marshall. The deal includes exclusive content, advertising rights, and live event experiences, launching with the 2024 NFL Season.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 12:20 pm

BURU

NUBURU has announced a partnership with Ohio State University's Center for Design and Manufacturing Excellence (CDME) and received a purchase order for its advanced BlueScan solution, which features the BL-250 laser.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 12:14 pm

CRL

Charles River Laboratories and Insightec have announced a five-year strategic collaboration to utilize focused ultrasound technology in drug discovery and preclinical development for neuroscience. This partnership aims to enhance the efficacy of neurological therapies.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 12:11 pm

ALXO

SNY

ALX Oncology has dosed the first patients in a Phase 1/2 study of evorpacept combined with Sanofi's SARCLISA for treating relapsed or refractory multiple myeloma. The study aims to overcome resistance to CD38 agents by targeting the CD47 pathway.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 12:06 pm

PBM

Psyence Biomedical shares are trading lower following the announcement of a worldwide, exclusive royalty-bearing IP licensing agreement with PsyLabs.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 12:05 pm

SHLS

Shoals Technologies Group has signed a non-binding MoU with UUES to develop localized solar solutions in Saudi Arabia and the region. They aim to establish a business for local solar EBOS manufacturing, aligning with Saudi Arabia's renewable energy goals.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 12:05 pm